Daily Discoveries
With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated his life to pursuing new and better treatments for patients with epilepsy. After earning his Ph.D. in Human Physiology from the University of Copenhagen in Denmark, Dr. Klitgaard conducted his postdoctoral work at the Pasteur Institute in Paris and Harvard Medical School. Motivated by a desire to see his research translated into workable solutions for patients, Dr. Klitgaard then joined the biopharmaceutical industry and eventually found his way to UCB, where he is currently Vice President and Fellow within New Medicines.